Alteration in microRNA-155 level correspond to severity of coronary heart disease

References

• Geneau R, Stuckler D, Stachenko S, et al. Raising the priority of preventing chronic diseases: a political process. Lancet. 2010; 376:1689–1698.
   PubMed Web of Science ®Google Scholar
• Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116:281–297.
   PubMed Web of Science ®Google Scholar
• Welten SM, Goossens EA, Quax PH, et al. The multifactorial nature of microRNAs in vascular remodelling. Cardiovasc Res. 2016;110:6–22.
   PubMed Web of Science ®Google Scholar
• Leistner DM, Boeckel JN, Reis SM, et al. Transcoronary gradients of vascular miRNAs and coronary atherosclerotic plaque characteristics. Eur Heart J. 2016;37:1738–1749.
   PubMed Web of Science ®Google Scholar
• Thum T, Condorelli G. Long noncoding RNAs and microRNAs in cardiovascular pathophysiology. Circ Res. 2015;116:751–762.
   PubMed Web of Science ®Google Scholar
• Kin K, Miyagawa S, Fukushima S, et al. Tissue- and plasma-specific MicroRNA signatures for atherosclerotic abdominal aortic aneurysm. J Am Heart Assoc. 2012;1:e000745.
   PubMed Web of Science ®Google Scholar
• Nazari-Jahantigh M, Egea V, Schober A, et al. MicroRNA-specific regulatory mechanisms in atherosclerosis. J Mol Cell Cardiol. 2015;89(Pt A):35–41.
   Web of Science ®Google Scholar
• Cui G, Li Z, Li R, et al. A functional variant in APOA5/A4/C3/A1 gene cluster contributes to elevated triglycerides and severity of CAD by interfering with microRNA 3201 binding efficiency. J Am Coll Cardiol. 2014;64:267–277.
   PubMed Web of Science ®Google Scholar
• Montorsi P, Ravagnani PM, Galli S, et al. Association between erectile dysfunction and coronary artery disease. Role of coronary clinical presentation and extent of coronary vessels involvement: the COBRA trial. Eur Heart J. 2006;27:2632–2639.
   PubMed Web of Science ®Google Scholar
• Dandona S, Stewart AF, Chen L, et al. Gene dosage of the common variant 9p21 predicts severity of coronary artery disease. J Am Coll Cardiol. 2010;56:479–486.
   PubMed Web of Science ®Google Scholar
• Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol. 1983;51:606.
   PubMed Web of Science ®Google Scholar
• Neeland IJ, Patel RS, Eshtehardi P, et al. Coronary angiographic scoring systems: an evaluation of their equivalence and validity. Am Heart J. 2012;164:547–552.e1.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Li HH, Yang R, et al. Association between circulating microRNA-208a and severity of coronary heart disease. Scand J Clin Lab Invest. 2017;77:379–384.
   PubMed Web of Science ®Google Scholar
• Zhou J, Yu L, Gao X, et al. Plasma microRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma. J Clin Oncol. 2011;29:4781–4788.
   PubMed Web of Science ®Google Scholar
• Rief M, Feger S, Martus P, et al. Acceptance of combined coronary CT angiography and myocardial CT perfusion versus conventional coronary angiography in patients with coronary stents–intraindividual comparison. PLoS One. 2015;10:e0136737.
   PubMed Web of Science ®Google Scholar
• Tian FJ, An LN, Wang GK, et al. Elevated microRNA-155 promotes foam cell formation by targeting HBP1 in atherogenesis. Cardiovasc Res. 2014;103:100–110.
   PubMed Web of Science ®Google Scholar
• Wei Y, Nazari-Jahantigh M, Chan L, et al. The microRNA-342-5p fosters inflammatory macrophage activation through an Akt1- and microRNA-155-dependent pathway during atherosclerosis. Circulation. 2013;127:1609–1619.
   PubMed Web of Science ®Google Scholar
• Yang Y, Yang L, Liang X, et al. MicroRNA-155 promotes atherosclerosis inflammation via targeting SOCS1. Cell Physiol Biochem. 2015;36:1371–1381.
   PubMed Web of Science ®Google Scholar
• Ghanbari M, Franco OH, de Looper HW, et al. Genetic variations in microrna-binding sites affect microrna-mediated regulation of several genes associated with cardio-metabolic phenotypes. Circ Cardiovasc Genet. 2015;8:473–486.
   PubMed Web of Science ®Google Scholar
• Niu J, Jin Z, Kim H, et al. MCP-1-induced protein attenuates post-infarct cardiac remodeling and dysfunction through mitigating NF-κB activation and suppressing inflammation-associated microRNA expression. Basic Res Cardiol. 2015;110:26.
   PubMed Web of Science ®Google Scholar
• Faraoni I, Antonetti FR, Cardone J, et al. miR-155 gene: a typical multifunctional microRNA. Biochim Biophys Acta. 2009; 1792:497–505.
   PubMed Web of Science ®Google Scholar
• Nazari-Jahantigh M, Wei Y, Noels H, et al. MicroRNA-155 promotes atherosclerosis by repressing Bcl6 in macrophages. J Clin Invest. 2012;122:4190–4202.
   PubMed Web of Science ®Google Scholar
• Zhang D, Cui Y, Li B, et al. miR-155 regulates high glucose-induced cardiac fibrosis via the TGF-β signaling pathway. Mol Biosyst. 2016;13:215–224.
   PubMed Web of Science ®Google Scholar
• Huang RS, Hu GQ, Lin B, et al. MicroRNA-155 silencing enhances inflammatory response and lipid uptake in oxidized low-density lipoprotein-stimulated human THP-1 macrophages. J Investig Med. 2010;58:961–967.
   PubMed Web of Science ®Google Scholar
• Banerjee A, Schambach F, DeJong CS, et al. Micro-RNA-155 inhibits IFN-gamma signaling in CD4+ T cells. Eur J Immunol. 2010;40:225–231.
   PubMed Web of Science ®Google Scholar
• Lu LF, Thai TH, Calado DP, et al. Foxp3-dependent microRNA155 confers competitive fitness to regulatory T cells by targeting SOCS1 protein. Immunity. 2009;30:80–91.
   PubMed Web of Science ®Google Scholar
• Cao RY, Li Q, Miao Y, et al. The Emerging Role of MicroRNA-155 in Cardiovascular Diseases. Biomed Res Int. 2016;2016: 9869208.
   PubMed Web of Science ®Google Scholar
• Faccini J, Ruidavets JB, Cordelier P, et al. Circulating miR-155, miR-145 and let-7c as diagnostic biomarkers of the coronary artery disease. Sci Rep. 2017;7:42916.
   PubMed Web of Science ®Google Scholar
• Wei Y, Zhu M, Corbalán-Campos J, et al. Regulation of Csf1r and Bcl6 in macrophages mediates the stage-specific effects of microRNA-155 on atherosclerosis. Arterioscler Thromb Vasc Biol. 2015;35:796–803.
   PubMed Web of Science ®Google Scholar
• Zhu GF, Yang LX, Guo RW, et al. microRNA-155 is inversely associated with severity of coronary stenotic lesions calculated by the Gensini score. Coron Artery Dis. 2014;25:304–310.
   PubMed Web of Science ®Google Scholar